3D Tissue Models
3rd Neurological Biomarkers
Hyatt Regency Mission Bay San Diego
1441 Quivira Rd
San Diego, CA USA
3rd Neurological Biomarkers 
Hyatt Regency Mission Bay San Diego
1441 Quivira Rd
San Diego

Schedule of Presentations:

Wednesday, March 19, 2014
12:55:00 Chairperson's Opening Remarks
13:00:00 A post-GWAS Method for Translating Statistical Associations to Disease-relevant Pathways Allen Roses
13:45:00 Lessons Learned from Oncology Biomarker and Companion Diagnostics Development Mara G Aspinall
14:30:00 The Reality of Incorporating Biomarkers and Genetics into Drug Development, are We There yet?
15:15:00 Afternoon Networking Break
15:50:00 Executive Panel: Companion Diagnostics & Partnering Strategies Scott D Patterson, Mara Aspinall
16:50:00 Day 1 Concludes
Thursday, March 20, 2014
06:00:00 Strategies for Using PET Imaging for Personalized Medicine
07:00:00 Continental Breakfast & Registration
08:00:00 Chairperson's Introduction Andreas Jeromin
08:15:00 Advances in Translational Neuroscience
09:05:00 The Michael J Fox Foundation Strategy for Discovery and Validation of Parkinson’s Disease Biomarkers Mark Frasier
09:30:00 Chief Executive Officer, Co-Founder, Molecular NeuroImaging
09:55:00 Morning Networking Break
10:30:00 Coalition Against Major Diseases (CAMD): Regulatory Science Accelerates Drug Development and Biomarkers for Neurodegenerative Diseases Diane Stephenson
10:55:00 Patrizia Fanara, Vice President, Neuroscience, KineMed Patrizia Fanara
11:45:00 Validation, Qualification and Approval of Biomarkers for Trial Stratification and Early Diagnostic Decisions for Alzheimer’s Disease
12:10:00 Lunch on Your Own
13:40:00 Richard Margolin, Senior Director, Biomarkers, Janssen Alzheimer Immunotherapy
14:30:00 A New Role for Nonprofits in Drug Discovery: The Myelin Repair Foundation’s Collaborative Research Approach to Accelerating the Next Generation of Multiple Sclerosis Therapeutics
14:55:00 How Biomarkers Can Change the Landscape of ALS Drug Discovery
15:20:00 Afternoon Networking Break
15:50:00 Can Biomarkers Predict Psychosis and Individualize Treatment in the Prodromal Period of Illness? Kristin Cadenhead
16:15:00 A Biomarker Panel and Gender Specific Algorithms to Aid in the Diagnosis of Major Depressive Disorder
16:40:00 Blood-based Gene-expression Predictors of PTSD Risk among Deployed Marines: A Pilot Study Ming Tsuang
17:05:00 Protein Biomarkers for Schizophrenia: Diagnosis and Stratification of Patients
17:30:00 Oral Presentations from Exemplary Submitted Abstracts
18:00:00 Networking Reception and Poster Session
Friday, March 21, 2014
07:00:00 Continental Breakfast
08:00:00 Systems Approaches to Disease: Emerging Technologies and Novel Strategies Including Blood Diagnostics Leroy Hood
08:45:00 The Biomarker Meets Predictive Analytics
09:10:00 Estimating Long-term Alzheimer’s Cascade from Short-term Data Michael Donohue
09:35:00 Revolutionizing Target Identification for Brain Diseases through Computational Systems Biology
10:00:00 Leveraging Big Bata and Big Analytics to Power Drug Discovery and Development Iya G. Khalil
10:25:00 Morning Networking Break
11:00:00 Novel Technologies in Biomarker Development Hongjie Dai
11:25:00 Uncovering Complex Patterns of Biology in Health and Disease with SOMAscan, a Breakthrough Proteomics Platform
11:50:00 Panel Discussion: Non-Profits Perspectives on CNS Biomarkers Andreas Jeromin, Mark Frasier, Diane Stephenson, Jennifer Chang
12:50:00 Lunch Provided by GTC
13:50:00 Panel Discussion: Regulatory & Reimbursement Trends in Biomarker Development Felix Frueh
14:50:00 Panel Discussion: Investment Perspectives & Funding Opportunities Keith Batchelder, Jeff Karan, John Reppas, Andrew Jay
15:50:00 Conference Concludes
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.